+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Allosteric inhibitors have distinct effects, but also common modes of action, in the HCV polymerase

Allosteric inhibitors have distinct effects, but also common modes of action, in the HCV polymerase

Biophysical Journal 108(7): 1785-1795

The RNA-dependent RNA polymerase from the Hepatitis C Virus (gene product NS5B) is a validated drug target because of its critical role in genome replication. There are at least four distinct allosteric sites on the polymerase to which several small molecule inhibitors bind. In addition, numerous crystal structures have been solved with different allosteric inhibitors bound to the polymerase. However, the molecular mechanisms by which these small molecules inhibit the enzyme have not been fully elucidated. There is evidence that allosteric inhibitors alter the intrinsic motions and distribution of conformations sampled by the enzyme. In this study we use molecular dynamics simulations to understand the structural and dynamic changes that result when inhibitors are bound at three different allosteric binding sites on the enzyme. We observe that ligand binding at each site alters the structure and dynamics of NS5B in a distinct manner. Nonetheless, our studies also highlight commonalities in the mechanisms of action of the different inhibitors. Each inhibitor alters the conformational states sampled by the enzyme, either by rigidifying the enzyme and preventing transitions between functional conformational states or by destabilizing the enzyme and preventing functionally relevant conformations from being adequately sampled. By illuminating the molecular mechanisms of allosteric inhibition, these studies delineate the intrinsic functional properties of the enzyme and pave the way for designing novel and more effective polymerase inhibitors. This information may also be important to understand how allosteric regulation occurs in related viral polymerases and other enzymes.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057161503

Download citation: RISBibTeXText

PMID: 25863069

DOI: 10.1016/j.bpj.2015.03.005

Related references

Allosteric Inhibitors Have Distinct Effects, but Also Common Modes of Action, in the HCV Polymerase. Biophysical Journal 111(10): 2336-2337, 2016

Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function. Neuron 89(5): 983-999, 2016

Two distinct modes of RecA action are required for DNA polymerase V-catalyzed translesion synthesis. Proceedings of the National Academy of Sciences of the United States of America 99(17): 11061-6, 2002

Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling. Plos Pathogens 12(8): E1005737, 2017

Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase. Viruses 9(6), 2018

Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. Journal of Virology 77(24): 13225-13231, 2003

Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration. Journal of Biological Chemistry 293(16): 6172-6186, 2018

Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors. Bioorganic and Medicinal Chemistry Letters 19(13): 3637-3641, 2009

The juxtamembrane sequence of the Hepatitis C virus polymerase can affect RNA synthesis and inhibition by allosteric polymerase inhibitors. Virus Genes 51(1): 1-11, 2016

An allosteric enzyme with 2 substrates: phosphofructokinase from rat muscle. IV. Conjugated action of 2 allosteric inhibitors, ATP and citrate. Bulletin de la Societe de Chimie Biologique 51(7): 1199-1210, 1969

Effect of DNA polymerase inhibitors on repair of ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-b-d-arabinofuranosylcytosine. Biochimica et Biophysica Acta - Molecular Basis of Disease 1227(1-2): 92-100, 1994

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes, Obesity & Metabolism 18(3): 203-216, 2016

Discovery of a Novel Chemical Class of mGlu(5) Allosteric Ligands with Distinct Modes of Pharmacology. Acs Chemical Neuroscience 1(10): 702-716, 2010

Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action. Neuropharmacology 85: 166-177, 2015

Hydrogen/Deuterium Exchange Kinetics Demonstrate Long Range Allosteric Effects of Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase. Journal of Biological Chemistry 291(19): 10078-10088, 2016